Home/Filings/4/0001235802-22-000017
4//SEC Filing

Neils Scott C 4

Accession 0001235802-22-000017

CIK 0001453593other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 4:12 PM ET

Size

8.1 KB

Accession

0001235802-22-000017

Insider Transaction Report

Form 4
Period: 2022-01-15
Neils Scott C
CFO and Assistant Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-15+109,164109,164 total
    Exercise: $0.65Exp: 2032-01-15Common Stock (109,164 underlying)
  • Award

    Common Stock, $0.000001 par value

    2022-01-15+88,983167,108 total
Footnotes (3)
  • [F1]These shares will vest and be issued with respect to 22,246 shares on each of January 15, 2023, January 15, 2024, and January 15, 2025 and with respect to 22,245 shares on January 15, 2026 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
  • [F2]Includes 78,125 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 88,983 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.
  • [F3]This option vests with respect to 27,291 shares on January 15, 2023 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.

Issuer

Xtant Medical Holdings, Inc.

CIK 0001453593

Entity typeother

Related Parties

1
  • filerCIK 0001902610

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:12 PM ET
Size
8.1 KB